The user is taking Bisoprolol and Paroxetine and is considering using Minoxidil 5% for hair loss. They are seeking opinions on combining these treatments.
The user is concerned about hair loss as a side effect of taking metoprolol while also using finasteride. They are seeking advice on whether finasteride can counteract potential hair loss from metoprolol.
Propranolol may cause hair loss, with users experiencing itchy scalps and thinning hair. Some users suggest stopping the medication or using treatments like minoxidil and finasteride to manage hair loss.
A 21-year-old with mild tachycardia on beta blockers is considering using topical 5% minoxidil for hair loss. They are seeking advice on its safety given their condition.
Mixing spironolactone with minoxidil for hair regrowth was discussed, with spironolactone being replaced by bicalutamide in a serum by Dr. Powers. Bicalutamide is not recommended for cis males due to potential side effects.
Minoxidil is used for hair loss and sometimes for high blood pressure, but it's outdated for the latter. For high blood pressure, it's combined with a beta blocker and diuretic to manage side effects.
The conversation discusses using oral spironolactone for hair loss in males when 5ari blockers fail. Concerns are raised about spironolactone's side effects, and alternatives like pyrilutamide and breezula are suggested.
Beta blockers may cause hair thinning as a side effect. The user is concerned about this and seeks others' experiences with hair loss while using beta blockers.
Latanoprost is discussed as a potential hair loss treatment, noted for its synergy with minoxidil and 5-AR inhibitors, but concerns include its effectiveness on scalp hair, cost, and potential skin darkening. Some users express interest in trying latanoprost or bimatoprost despite limited real-world evidence.
Using licorice to counteract the blood pressure-lowering effects of oral minoxidil. Concerns about licorice affecting potassium levels and minoxidil's effectiveness were raised.
P-1075 is a more potent hair growth agent than Minoxidil, but it poses significant heart risks, making it unsafe for use. Despite promising results in macaques, concerns about its cardiotoxicity in rats have halted its development.
Minoxidil can cause significant drops in blood pressure for some users due to systemic absorption, so monitoring is advised. Most users are unlikely to experience this side effect.
Low-dose oral minoxidil is used for hair loss and does not significantly affect blood pressure but may increase heart rate and cause hypotensive symptoms. Some users experience side effects like palpitations and shortness of breath, while others find it effective; topical minoxidil with tretinoin is also considered.
A 22-year-old woman is considering switching from topical to oral minoxidil due to the inconvenience of the topical form and is currently taking 25mg spironolactone. Users suggest starting with a higher dose of oral minoxidil, like 1.25mg, for effectiveness and share their experiences with dosing and side effects.
The user is applying topical finasteride with stemoxydine for hair loss and has noticed hair thickening but no regrowth after two months. They also report high SHBG and prolactin levels and a lack of morning erections, even on low doses of medication.
Beta-sitosterol may inhibit 5-alpha reductase type 2 enzyme, potentially reducing DHT levels and promoting hair growth, similar to finasteride but possibly with fewer side effects. Its effectiveness and side effects compared to other treatments like saw palmetto and finasteride remain uncertain due to limited research.
Hair loss treatments discussed include 200mg Spiro, bicalutamide, and finasteride. Endocrinologist advises against bicalutamide and finasteride due to potency and risks.
Reducing the dose of RU58841 from 25mg to 7.5mg topically helped minimize heart palpitations. Users discussed the cardiac effects of RU58841 and minoxidil, noting that no treatment is completely free of side effects.
A 23-year-old from Denmark is considering oral minoxidil for hair loss while already using finasteride, but is concerned about its safety due to a 1st degree AV block. They plan to consult a doctor, possibly a cardiologist, to determine if oral minoxidil is safe and how to obtain it if not available through Denmark's public health system.
Clascoterone in Winlevi, a topical AR antagonist, is being re-examined due to concerns about HPA axis suppression in adolescents, but it's unlikely to be banned for adult use in androgenetic alopecia (AGA). The European Medicines Agency recommended refusing Winlevi for acne vulgaris, but this may not affect Breezula's approval for AGA.
A 23-year-old man with hair loss, despite using dutasteride, oral minoxidil, and RU58841, is considering bicalutamide for regrowth but is concerned about feminization. Alternatives like topical estrogen, JXL069, and spironolactone are discussed, with suggestions to explore thyroid levels and other potential underlying conditions.
The user must stop minoxidil due to a heart murmur and is considering alternatives like nanoxidil or stemoxydine while continuing dutasteride. Suggestions include adding pyrilutamide and alfatradiol or switching to topical minoxidil at a lower concentration.
A user is concerned about using more minoxidil than prescribed to cover their hair loss area and mentions taking spironolactone pills. Another user advises against men taking oral spironolactone due to significant hormonal effects.
Taking psyllium with oral minoxidil reduced heart palpitations but may also reduce the drug's effectiveness. Users suggest splitting the minoxidil dose or consulting a doctor for safer alternatives.
Oral minoxidil can cause cardiovascular issues, but an extended release formulation may reduce side effects like heart rate and blood pressure spikes. This new formulation offers a safer option for those who previously had to stop due to health concerns.